Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis.
Stefano GelibterMarco PisaTommaso CroeseAnnamaria FinardiAlessandra MandelliFrancesca SangalliBruno ColomboVittorio MartinelliGiancarlo ComiMassimo FilippiRoberto FurlanPublished in: Annals of neurology (2021)
Our results confirm that CSF myeloid microvesicles are a clinically meaningful biomarker of neuroinflammation and microglial/macrophage activity in vivo. These findings may support a possible use in clinical practice during diagnostic workup and prognostic assessment. ANN NEUROL 2021;90:253-265.
Keyphrases
- multiple sclerosis
- clinical practice
- lipopolysaccharide induced
- dendritic cells
- bone marrow
- lps induced
- acute myeloid leukemia
- inflammatory response
- spinal cord
- traumatic brain injury
- adipose tissue
- neuropathic pain
- cognitive impairment
- white matter
- immune response
- neural network
- cerebrospinal fluid
- blood brain barrier